Cargando…

Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency

BACKGROUND: Clinical trials of the mRNA coronavirus disease 2019 (COVID-19) vaccines excluded individuals with primary antibody deficiencies. OBJECTIVE: To evaluate whether antibody and T-cell responses to mRNA COVID-19 vaccination in patients with common variable immunodeficiency (CVID) and specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenthal, Jamie A., Papa, Michelle Premazzi, Sanz, Marta, Nicholes, Samuel, Holmberg, Carissa S., Bosque, Alberto, Keswani, Anjeni, Amdur, Richard, Lynch, Rebecca M., Soriano-Sarabia, Natalia, Ein, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891791/ https://www.ncbi.nlm.nih.gov/pubmed/36736722 http://dx.doi.org/10.1016/j.anai.2023.01.025

Ejemplares similares

Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019
por: Rosenthal, Jamie A., et al.
Publicado: (2021)

Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019
por: Keswani, Anjeni, et al.
Publicado: (2020)

Investigating air pollution as a contributor to health disparities during the coronavirus disease 2019 pandemic
por: Marwah, Harleen, et al.
Publicado: (2021)

Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination
por: Abo-helo, Nizar, et al.
Publicado: (2021)

The Eyes Have It: Eyelid Swelling and Rash in a 79-year-old Woman With Macular Degeneration
por: Kleris, Renee S., et al.
Publicado: (2018)

The Future of Telehealth in Allergy and Immunology Training
por: Keswani, Anjeni, et al.
Publicado: (2020)

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
por: Kinoshita, Hannah, et al.
Publicado: (2021)

Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
por: Abo-Helo, Nizar, et al.
Publicado: (2022)

FRI568 Hashimoto’s Thyroiditis With Negative Antibodies In Association With Common Variable Immunodeficiency
por: Ebrahim, Ismail C, et al.
Publicado: (2023)

Compassionate Use of REGEN-COV(®) in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders
por: Stein, David, et al.
Publicado: (2021)

Monoclonal antibody treatment of COVID-19 in a pregnant woman with common variable immunodeficiency
por: Aberumand, Babak, et al.
Publicado: (2022)

A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency
por: Mullur, Jyotsna, et al.
Publicado: (2021)

Antibody-specific immunoregulation and the immunodeficiency of aging
Publicado: (1981)

Coronavirus disease 2019 antibody testing in pregnancy
por: Zullo, Fabrizio, et al.
Publicado: (2020)

The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
por: Fill, Lauren, et al.
Publicado: (2020)

Antibodies to watch in 2019
por: Kaplon, Hélène, et al.
Publicado: (2018)

Deep characterization of human γδ T cell subsets defines shared and lineage-specific traits
por: Sanz, Marta, et al.
Publicado: (2023)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Antibody imaging to speed vaccine work
por: Wong, Carissa
Publicado: (2022)

The Spectrum of Disease Manifestations in Patients with Common Variable Immunodeficiency Disorders and Partial Antibody Deficiency in a University Hospital
por: Maarschalk-Ellerbroek, L. J., et al.
Publicado: (2012)

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application
por: Ding, Chengchao, et al.
Publicado: (2021)

Antibody testing for coronavirus disease 2019: not ready for prime time
por: Duong, Yen T, et al.
Publicado: (2020)

Hemodialysis patients with coronavirus disease 2019: reduced antibody response
por: Beppu, Hiroko, et al.
Publicado: (2021)

Characteristics and Prognosis of Antibody Non-responders With Coronavirus Disease 2019
por: Ding, Junyu, et al.
Publicado: (2022)

Post-Infection Immunodeficiency Virus Control by Neutralizing Antibodies
por: Yamamoto, Hiroyuki, et al.
Publicado: (2007)

Detection of neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with common variable immunodeficiency after immunization with messenger RNA vaccines
por: Romano, Ciro, et al.
Publicado: (2021)

Acknowledgement to Reviewers of Antibodies in 2019
Publicado: (2020)

Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman-Steiner and Roifman syndromes
por: Bogaert, Delfien J., et al.
Publicado: (2017)

The B-cell compartment in antibody-deficient infants and young children – developing common variable immunodeficiency or transient immune maturation?
por: Szczawinska-Poplonyk, Aleksandra, et al.
Publicado: (2016)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
por: Nielsen, Bibi Uhre, et al.
Publicado: (2022)

Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
por: Jin, Yujiao, et al.
Publicado: (2020)

Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
por: Liao, Xuejiao, et al.
Publicado: (2022)

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
por: Milota, Tomas, et al.
Publicado: (2023)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
por: Pulvirenti, Federica, et al.
Publicado: (2021)

Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score
por: Johnson, Patrick W., et al.
Publicado: (2023)

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
por: Brown, Jennifer A, et al.
Publicado: (2023)

Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques
por: Pahar, Bapi, et al.
Publicado: (2016)

Coronavirus Disease 2019 and Primary Antibody Deficiencies. Comment on Milota et al. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023, 12, 109
por: Özdemir, Öner
Publicado: (2023)

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_485cq5252s822tuneg9l7f6rig